Cargando…
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
An ideal anti-SARS-CoV-2 antibody would resist viral escape(1–3), have activity against diverse SARS-related coronaviruses(4–7), and be highly protective through viral neutralization(8–11) and effector functions(12,13). Understanding how these properties relate to each other and vary across epitopes...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043444/ https://www.ncbi.nlm.nih.gov/pubmed/33851154 http://dx.doi.org/10.1101/2021.04.06.438709 |